CRISPR/Cas9-repaired iPSC-cardiomyocytes display a restored function and a normalized muscle contraction.© Cyganek, UMG

CRISPR/Cas9 – GENE EDITING: New therapeutic approach for congenital heart defects

Scientists at the Heart Center of the University Medical Center Göttingen have for the first time found an approach for a personalised therapy option with “gene editing” for the Noonan Syndrome. Publication in the renowned journal “Circulation“.

Link to the press release